EX-10.4 2 d591354dex104.htm EX-10.4License and Supply Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • October 25th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 25th, 2013 Company IndustryTHIS AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT is entered into as of 22 December, 2009 (the “Amended and Restated Agreement”), between Oxford Immunotec Ltd (“OXFORD”), having its registered office at 94C Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom and Statens Serum Institut (“SSI”), a governmental enterprise under the laws of the Kingdom of Denmark, with offices at 5, Artillerivej, 2300 Copenhagen S, Denmark.